Information Related to Clinical Trials
TaiRx’s novel anti-cancer drug CVM-1118 and add-on therapy for sepsis drug Rexis® are currently in Phase II and Phase III clinical trials, respectively.
Clinical trial of Rexis® as an add-on therapy for patients with sepsis and septic shock
- Center for Drug Evaluation, Taiwan:(Click here)
If you would like to know more information regarding the clinical trials, please contact the nearest clinical trial center.